Aims & Scope
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.
Current Cancer Drug Targetspublishes original research articles, letters, reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.
Ranking and Category
73rd of 211 in Oncology
Bentham Press Release — NEWS
Emerging Sources Citation Index (ESCI) indexes Current Drug Safety
News release date: June 22, 2016
Dubai, UAE, June 22, 2016: The Bentham Science journal Current Drug Safety has been accepted for inclusion in Emerging Sources Citation Index (ESCI) and will appear in WoS by August 2016.
Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. The topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, and post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety. For more information about the journal, please visit here
As a new index in the Web of Science™ Core Collection, Emerging Sources Citation Index (ESCI) expands the citation universe and reflects the growing global body of science and scholarly activity. ESCI complements the highly selective indexes by providing earlier visibility for sources under evaluation as part of SCIE, SSCI, and AHCI’s rigorous journal selection process. Inclusion in ESCI provides greater discoverability which leads to measurable citations and more transparency in the selection process.
- New Issue Published Current Cancer Drug Targets Vol 18 issue 3
- New Issue Published Current Cancer Drug Targets Vol 18 issue 3
- New Issue Published Current Cancer Drug Targets Vol 18 issue 2
- New Issue Published Current Cancer Drug Targets Vol 18 issue 1
- Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
- New Issue Published Current Cancer Drug Targets Vol 17 issue 9
- Free Trial Request
- Most Accessed Article : Influence of Aldo-keto Reductase 1C3 in Prostate Cancer – A Mini Review
- New Issue Published Current Cancer Drug Targets Vol 17 issue 8
- Free Trial Offer
- Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
- New Issue Published Current Cancer Drug Targets Vol 17 issue 7
- Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
- Call For Paper
- Free Trial Request
- Most Accessed Article:Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
- New Issue Published Current Cancer Drug Targets Vol 17 issue 6
- Open Access Article : “HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles”
- Call For Paper
- Free Trial Request
- Most Accessed Article Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
- New Issue Published Current Cancer Drug Targets Vol. 17 Issue 5
- Open Access Article: Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
- Call For Paper
- Free Trial Request
- Open Access Article: Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition
- Most Accessed Article: Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
- Call For Paper
- Free Trial Request
- Open Access Article: Pleiotropic Role of HSF1 in Neoplastic Transformation
- New Issue Published Current Cancer Drug Targets Vol. 17 Issue 3
- Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
- Free Online Issue Current Cancer Drug Targets Vol. 17 Issue 1
- Call For Paper
- Free Trial Request
- New Issue Published Current Cancer Drug Targets Vol. 17 Issue 2
- Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
- Highlighted Article: Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
- Open Access Article: A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
- Most Accessed Article: Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs)
- Call For Paper
- Free Trial Request
- Podcast for (Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies)
- Free Online Issue of Current Cancer Drug Targets
- New Issue Published Current Cancer Drug Tragets Vol. 17 Issue 1
- Highlighted Article: Deregulation of Apoptosis – Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
- Free Trial Request
- Call For Paper
- Highlighted Article: Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
- Most Cited Article: Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways
- Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
- Indian Authors have made substantial contributions to Bentham Science Journal Current Cancer Drug Targets
- Online Free Trail Request
- Mechanisms & therapeutic targets of microRNA-associated chemoresistance in epithelial ovarian cancer
- Recent advances in site specific conjugations of antibody drug conjugates
- Issue ::: Current Cancer Drug Targets, 16 Issue 7
- Open Access Plus Article in the journal Current Cancer Drug Targets
- Current Cancer Drug Targets
- Highlighted Article Flyer for the journal “Current Topics in Medicinal Chemistry”